NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Xlife Sciences AG

Xlife Sciences AG

Overview

Xlife Sciences AG is a Swiss-listed life sciences incubator and accelerator that identifies, develops, and commercializes early-stage research projects from universities and research institutions across technology platforms, biotechnology, medical technology, and artificial intelligence.

Year Founded

2019

Portfolio Companies

12

Investments

Xlife Sciences AG investments
CompanyDateStageLead
VERAXA BiotechApr 2025M&ACo-investor
4D LifetecOct 2023Early FundingLead
novaxomxMar 2022Joint VentureCo-investor
Lysatpharma GmbHJan 2020SeedCo-investor
saniva diagnostics GmbHNov 2019SeedLead

Key People

Valery Lorenz

Investor

Sector & Stage Mix

Industry, funding stage, and valuation band breakdowns.

Premium
SeedSeries ASeries BGrowth

Unlock portfolio analytics

Sign up to view full sector, stage, and valuation breakdowns for this investor.

Investment Activity

Yearly cadence, pace, and funding raised over time.

Premium
2021
2022
2023
2024
2025
2026

Unlock portfolio analytics

Sign up to explore yearly investment trends and funding raised over time.

FAQ

Firmographic Details

HeadquartersZurich
Year Founded2019

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.